These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20179926)

  • 1. Mechanisms of platelet recovery in ITP associated with therapy.
    Pang SJ; Lazarus AH
    Ann Hematol; 2010 Jul; 89 Suppl 1():31-5. PubMed ID: 20179926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A; Konopka L; Maślanka K
    Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current treatment of primary immune thrombocytopenia].
    Lozano ML; Vicente V
    Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
    Imbach P; Morell A
    Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
    Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs.
    Witkowski M; Witkowska M; Robak T
    Eur J Haematol; 2019 Dec; 103(6):531-541. PubMed ID: 31449692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic immune thrombocytopenic purpura. Looking for something better. Review].
    Vizcaíno G; Diez-Ewald M; Vizcaíno-Carruyo J
    Invest Clin; 2009 Mar; 50(1):95-108. PubMed ID: 19418731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
    Imbach PA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenia in adults: an update.
    Thota S; Kistangari G; Daw H; Spiro T
    Cleve Clin J Med; 2012 Sep; 79(9):641-50. PubMed ID: 22949345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of adult idiopathic thrombocytopenic purpura.
    Cines DB; McMillan R
    Annu Rev Med; 2005; 56():425-42. PubMed ID: 15660520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.